These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15972697)

  • 1. Novel protein and poxvirus-based vaccine combinations for simultaneous induction of humoral and cell-mediated immunity.
    Hutchings CL; Gilbert SC; Hill AV; Moore AC
    J Immunol; 2005 Jul; 175(1):599-606. PubMed ID: 15972697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule.
    Gherardi MM; Pérez-Jiménez E; Nájera JL; Esteban M
    J Immunol; 2004 May; 172(10):6209-20. PubMed ID: 15128809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus.
    Kent SJ; Zhao A; Best SJ; Chandler JD; Boyle DB; Ramshaw IA
    J Virol; 1998 Dec; 72(12):10180-8. PubMed ID: 9811759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral vaccination with modified vaccinia virus Ankara attached covalently to TMPEG-modified cationic liposomes overcomes pre-existing poxvirus immunity from recombinant vaccinia immunization.
    Naito T; Kaneko Y; Kozbor D
    J Gen Virol; 2007 Jan; 88(Pt 1):61-70. PubMed ID: 17170437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE; Abaitua F; Rodríguez D; Esteban M
    Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice.
    Zhao HP; Sun JF; Li N; Sun Y; Wang Y; Qiu HJ
    Vet Immunol Immunopathol; 2009 Oct; 131(3-4):158-66. PubMed ID: 19411115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge.
    Hutchings CL; Birkett AJ; Moore AC; Hill AV
    Infect Immun; 2007 Dec; 75(12):5819-26. PubMed ID: 17908809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus.
    Sedegah M; Weiss W; Sacci JB; Charoenvit Y; Hedstrom R; Gowda K; Majam VF; Tine J; Kumar S; Hobart P; Hoffman SL
    J Immunol; 2000 Jun; 164(11):5905-12. PubMed ID: 10820272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting murine immune responses to selected T cell- or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen.
    Schirmbeck R; Zheng X; Roggendorf M; Geissler M; Chisari FV; Reimann J; Lu M
    J Immunol; 2001 Jan; 166(2):1405-13. PubMed ID: 11145726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys.
    Grandpre LE; Duke-Cohan JS; Ewald BA; Devoy C; Barouch DH; Letvin NL; Reinherz EL; Baden LR; Dolin R; Seaman MS
    Vaccine; 2009 Mar; 27(10):1549-56. PubMed ID: 19168105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective efficacy and hepatitis B virus clearance in mice enhanced by cell-mediated immunity with novel prime-boost regimens.
    Chuai X; Chen P; Chen H; Wang W; Deng Y; Ruan L; Li W; Tan W
    J Viral Hepat; 2017 Apr; 24(4):337-345. PubMed ID: 27885748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus.
    Anderson RJ; Hannan CM; Gilbert SC; Laidlaw SM; Sheu EG; Korten S; Sinden R; Butcher GA; Skinner MA; Hill AV
    J Immunol; 2004 Mar; 172(5):3094-100. PubMed ID: 14978115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified-vaccinia-virus-Ankara (MVA) priming and fowlpox-virus booster elicit a stronger CD8+ T-cell response in mice against an HIV-1 epitope than does a DNA/poxvirus prime-booster approach.
    Vázquez-Blomquist D; Quintana D; Duarte CA
    Biotechnol Appl Biochem; 2004 Jun; 39(Pt 3):313-8. PubMed ID: 15154843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge.
    Payette PJ; Ma X; Weeratna RD; McCluskie MJ; Shapiro M; Engle RE; Davis HL; Purcell RH
    Intervirology; 2006; 49(3):144-51. PubMed ID: 16428890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cationic transfersomes based topical genetic vaccine against hepatitis B.
    Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
    Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with multiple vaccine modalities induce strong HIV-specific cellular and humoral immune responses.
    Hallengärd D; Applequist SE; Nyström S; Maltais AK; Marovich M; Moss B; Earl P; Nihlmark K; Wahren B; Bråve A
    Viral Immunol; 2012 Oct; 25(5):423-32. PubMed ID: 23035853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-MVA-protein vaccination of rhesus macaques induces HIV-specific immunity in mucosal-associated lymph nodes and functional antibodies.
    Chege GK; Burgers WA; Müller TL; Gray CM; Shephard EG; Barnett SW; Ferrari G; Montefiori D; Williamson C; Williamson AL
    Vaccine; 2017 Feb; 35(6):929-937. PubMed ID: 28069361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multigene HIV type 1 subtype C modified vaccinia Ankara (MVA) vaccine efficiently boosts immune responses to a DNA vaccine in mice.
    Shephard E; Burgers WA; Van Harmelen JH; Monroe JE; Greenhalgh T; Williamson C; Williamson AL
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):207-17. PubMed ID: 18240963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
    Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
    Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.